LS
Insider
Lynn Seely
President and CEOLynn Seely (President and CEO) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Lyell Immunopharma, Inc. (LYEL). The largest single filing was $174K of LYEL (7,455 sh × $23.39, as filed), executed Feb 11.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$323K
shares × price, as filed
Last traded
Aug 21
Filed Aug 25
Median ADV $2.9M across their filed names
Open performance→Volume by month
Buys $0
Sells $323K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
LYELRecent filings
LYELSALE
Lyell Immunopharma, Inc.
View filing →
$149K9,589 sh × $15.54
Exec Aug 21
Filed Aug 25 · 4:06 PM ET LYELSALE Lyell Immunopharma, Inc. View filing → $174K
7,455 sh × $23.39
Exec Feb 11
Filed Feb 12 · 5:30 PM ET LYELPURCHASE Lyell Immunopharma, Inc. View filing → –
175,000 sh · price not plausible
Exec Mar 14 2025
Filed Mar 18 2025 · 5:30 PM ET